Anxiety Clinical Trial
Official title:
Evaluation of a Fixed Combination of Herbal Extracts to Prevent Symptoms Alcohol-induced Hangovers : A Randomized, Double Blind Placebo Controlled Crossover Study.
The primary objective of the study is to test whether the tested Product LACIME Anti-hangover is effective in preventing the signs and symptoms of alcohol-induced hangover (such as headache, impaired memory, depression, anxiety, weakness, trouble sleeping and concentrating, nausea, dizziness, sleepiness, thirsty, dry mouth, sweating, sensitivity to light and sounds, vision problems) in healthy subjects.
LACIME Anti-hangover is a food supplement under the form of a syrup (water/glycerin based)
containing plan extracts, each one having choleretic properties.
40 healthy subjects will be tested in a randomized, double-blind, placebo-controlled,
crossover trial.
The participants will have to attend the 2 phases of the study during which they will receive
in a blind way a product (LACIME Anti-hangover or PLACEBO):
If a participant has received LACIME Anti-hangover for Phase 1, the same participant will
receive the PLACEBO for Phase 2 and vice versa.
Inclusion Criteria:
For inclusion in the study subjects must fulfil all the following criteria:
20-30 years old healthy males and females, Body weight (kg): 60 - 80 in man and 60-70 in
women, People who consume alcohol occasionally and who already have to deal with hangovers
Healthy volunteers who consume alcohol regularly and moderately, Having given their free,
informed and express consent in writing Co-operative, informed of the need and duration of
the controls which make it possible to achieve full adherence to the protocol in place.
Exclusion Criteria:
Excluded from participating in the study:
Volunteers consuming larger amounts of alcohol (more than 2 glasses of alcohol per day)
Volunteers taking medication or food supplements that may affect alcohol metabolism.
Women who are pregnant or breastfeeding or plan to become pregnant during the study Subjects
with illnesses which may conflict with the investigator's interpretation, if the subject
participated in the study Subject planning to change his/her lifestyle during the study
(diet, physical activity, etc.) Smoker Subject participating in another study during the
clinical study period.
- At the first medical visit all volunteers will be checked for illegibility, randomized,
and sign written informed consent including an obligation that they will not take
alcohol within the next week and come to the study site a week later at least 3 hours
after the last meal.
- At the second visit, participants will attend the study site, where each will fill
Hangover Severity Symptoms (HSS) form, donate blood and urine for initial analysis.
Then participants take the Product LACIME Anti-hangover or PLACEBO and after 1hour will start
to consume alcohol during two hours with meal (3 sandwiches with cheese or ham) on each of
the 2 study phases.
Drink consumption, the composition and sequence:
300 ml of Brandy (41% vol. alcohol) corresponding to an intake of 123 ml or 99 g of alcohol
300 ml of Champagne (13% vol. alcohol) corresponding to an intake of 40 ml or 32 g of alcohol
This will ensure a 100% hangover syndrome and a total intake of 131 g of alcohol (a dose of
approximately 2 g / kg).
Such a dose will provide a peak concentration after 1 hour and should allow to determine the
alcohol 15 hours after absorption.
Smaller doses are usually not detectable after 10-12 hours. (Jones, 2008).
D2 test, blood sampling and urine sampling under medical control is achieved before alcohol
intake.
D2 test, blood sampling and urine sampling under medical control is achieved 1h, 4h and 15h
after alcohol consumption.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05777044 -
The Effect of Hatha Yoga on Mental Health
|
N/A | |
Recruiting |
NCT04680611 -
Severe Asthma, MepolizumaB and Affect: SAMBA Study
|
||
Completed |
NCT04748367 -
Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care
|
N/A | |
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05563805 -
Exploring Virtual Reality Adventure Training Exergaming
|
N/A | |
Completed |
NCT04579354 -
Virtual Reality (VR) Tour to Reduce Preoperative Anxiety Before Anaesthesia
|
N/A | |
Completed |
NCT03535805 -
Transdiagnostic, Cognitive and Behavioral Intervention for in School-aged Children With Emotional and Behavioral Disturbances
|
N/A | |
Completed |
NCT03457714 -
Guided Internet Delivered Cognitive-Behaviour Therapy for Persons With Spinal Cord Injury: A Feasibility Trial
|
||
Recruiting |
NCT05956912 -
Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
|
||
Active, not recruiting |
NCT05302167 -
Molehill Mountain Feasibility Study.
|
N/A | |
Completed |
NCT05881681 -
A Mindfulness Approach to UA for Afro-descendants
|
N/A | |
Completed |
NCT05588622 -
Meru Health Program for Cancer Patients With Depression and Anxiety
|
N/A | |
Active, not recruiting |
NCT04961112 -
Evaluating the Efficacy of Cranial Electrotherapy Stimulation in Mitigating Anxiety-induced Cognitive Deficits
|
N/A | |
Terminated |
NCT04612491 -
Pre-operative Consultation on Patient Anxiety and First-time Mohs Micrographic Surgery
|
||
Completed |
NCT05980845 -
The Effect Nature Sounds and Music on Hemodialysis Patients
|
N/A | |
Recruiting |
NCT05449002 -
Digital Single Session Intervention for Youth Mental Health
|
N/A | |
Completed |
NCT05585749 -
Virtual Reality Application on Pain Intensity and Anxiety Level in Endoscopy Patients
|
N/A | |
Terminated |
NCT03272555 -
WILD 5 Wellness: A 30-Day Intervention
|
N/A | |
Recruiting |
NCT05997849 -
Development of a Multiplatform Mental Health Mobile Tool
|
N/A | |
Completed |
NCT06421233 -
The Effect of Endorphin Massage Applied to Postpartum Women on Anxiety and Fatigue Levels
|
N/A |